Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
3.675
+0.065 (1.80%)
At close: Nov 4, 2024, 4:00 PM
3.580
-0.095 (-2.59%)
After-hours: Nov 4, 2024, 4:23 PM EST

Kiora Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
1146192741
Upgrade
Market Cap Growth
206.06%-34.81%-67.75%-29.68%-33.02%100.75%
Upgrade
Enterprise Value
-17-1182538
Upgrade
Last Close Price
3.674.7030.87543.601774.803607.20
Upgrade
PE Ratio
3.30-0.19-0.18-1.06-3.30-
Upgrade
PS Ratio
0.49---2252.9815.10
Upgrade
PB Ratio
0.330.660.541.312.796.13
Upgrade
P/FCF Ratio
2.30-0.42-0.59-1.78-3.70-4.97
Upgrade
P/OCF Ratio
2.28-0.42-0.59-1.79-3.71-4.97
Upgrade
EV/Sales Ratio
-1.17---2038.0714.23
Upgrade
EV/EBITDA Ratio
-2.960.16-0.14-0.78-3.29-5.83
Upgrade
EV/EBIT Ratio
-2.970.16-0.14-0.78-3.27-5.79
Upgrade
EV/FCF Ratio
-3.950.14-0.14-0.77-3.35-4.69
Upgrade
Debt / Equity Ratio
0.000.020.010.010.060.01
Upgrade
Debt / FCF Ratio
0.02-0.01-0.01-0.02-0.08-0.01
Upgrade
Asset Turnover
0.53---0.000.22
Upgrade
Quick Ratio
19.022.762.245.210.642.67
Upgrade
Current Ratio
19.222.902.355.590.873.06
Upgrade
Return on Equity (ROE)
13.69%-142.88%-104.54%-113.30%-83.92%-91.22%
Upgrade
Return on Assets (ROA)
12.96%-33.54%-34.55%-37.30%-36.91%-33.87%
Upgrade
Return on Capital (ROIC)
16.78%-61.27%-50.98%-52.67%-55.15%-52.80%
Upgrade
Earnings Yield
24.45%-311.53%-220.45%-72.08%-25.26%-17.50%
Upgrade
FCF Yield
43.40%-237.92%-169.24%-56.21%-27.01%-20.10%
Upgrade
Buyback Yield / Dilution
-1066.67%-561.21%-203.73%-110.04%--
Upgrade
Total Shareholder Return
-1066.67%-561.21%-203.73%-110.04%--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.